Browser View

This sponsored message does not reflect the opinion of CIRSE,
nor does it engage their responsibility


	BD @ CIRSE 2024 ‌14-‌18 Sep‌tember 20‌24

Proven patency since 2021

Do you care about safety profile in AV fistula stenosis?

AVeNew is the first large, prospective randomized trial studying whether a covered stent would provide a benefit compared to PTA for the treatment of AV Fistula stenosis.

Are you in Lisbon at CIRSE 2024?

Don't miss the opportunity to join us at our in-person Masterclass for the opportunity to learn more!

Title: Evidences and Clinical impact for covered stent in Vascular Access

Date: Tues‌day‌ 17‌^th Sep‌tember, 2024

Time: 13:30 - 15:30 WEST

Location: Room 1.05, 1st Floor

Space is limited and subject to first come first served.

Enrol here

Enrol to gain access to the AVeNEW 24-month data trial and the opportunity to register your interest for our in-person Masterclass at CIRSE 2024.

Faculty

M. Tozzi
Italy

B. Dolmatch
USA

BD Switzerland
Sarl Terre Bonne Park – A4, Route De Crassier, 17, 1262 Eysins, Vaud, Switzerland
T: +41 21 556 30 00

Please consult product labels and instructions for use for indications, contraindications, hazards, warnings and precautions.

BD, the BD logo and Covera are trademarks of Becton, Dickinson and Company or its affiliates. © 2024 BD. All rights reserved. Illustrations by Mike Austin. © 2024. All rights reserved. BD-133105
Privacy Notice

You have received this sponsored message as a part of our mailing list service.
If you wish to unsubscribe from CIRSE congress related notifications, sponsored messages and other promotional emails, you may UNSUBSCRIBE at any time

unsubscribe